Skip to content

LPB Combined with QLB Using Single-needle Technique (LPQLB-SNT) for Hip Arthroplasty

Ultrasound-guided Lumbar Plexus Combined with Quadratus Lumborum Block Using Single-needle Technique with Shamrock Method for Hip Arthroplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04266236
Acronym
LPQLB-SNT
Enrollment
84
Registered
2020-02-12
Start date
2020-07-09
Completion date
2024-06-30
Last updated
2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Local, Hip Fractures, Hip Osteoarthritis, Osteonecrosis of Femoral Head

Keywords

lumbar plexus block, quadratus lumorum block, total hip arthroplasty, single-needle, shamrock approach

Brief summary

Total hip arthroplasty (THA) is one of the most successful orthopedic procedures to effectively relieve pain and restore function in patients with hip osteoarthritis, osteonecrosis of femoral head and hip fracture.The Lumbar Plexus Block (LPB) is currently used as the standard regional anesthesia technique to provide postoperative pain management after THA. The lumbar plexus (LP) originates from T12 to L5. In general, multiple-needle nerve blockade procedure is needed to block different branches of LP. Therefore, we need more time to finish the regional anethesia procedure and it's not easy for an inexperienced anesthesiologist to master the technique absolutely. In addition, multiple injections will increase the discomfort of the patients. We aim to investigate the effects of lumbar plexus combined with quadratus lumborum block using single-needle technique with Shamrock method as an alternative regional anesthesia.

Interventions

PROCEDUREL3 LPB

ultrasound-guided L3 lumbar plexus block

PROCEDUREL4 LPB

ultrasound-guided L4 lumbar plexus block

PROCEDURET12 block

ultrasound-guided thoracic 12th segment nerve block

PROCEDUREL3 QLB

ultrasound-guided quadratus lumborum block at L3 level

DRUG0.375%ropivacaine 25 ml (Raropin)

0.375%ropivacaine (Raropin) 25ml will be given

DRUG0.375%ropivacaine 40 ml (Raropin)

0.375%ropivacaine (Raropin) 40ml will be given

PROCEDUREGeneral anesthesia with tracheal intubation

General anesthesia with tracheal intubation will be induced with sufentanil, propofol, vecuronium for every patient before the operation and maintained with sevoflurane during the operation

Sponsors

Shanghai 6th People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Body mass index (BMI) between 18.5 and 30kg/m2 and the weight ≥50kg 2. American Society of Anesthesiologists (ASA) classification I-II 3. Postero-lateral operative incision approach unilateral hip arthroplasty 4. Aged 18-75

Exclusion criteria

1. Patient refusal 2. Patients with coagulopathy or on therapeutic anticoagulation 3. Pregnancy 4. Multiple trauma 5. Hypersensitivity or allergy to ropivacaine 6. History of ankylosing spondylitis or spinal surgery 7. Lower extremity neuropathy 8. Unable to communicate

Design outcomes

Primary

MeasureTime frameDescription
sensory block assessment30 minutes after nerve block procedureThe sensory block will be assessed by cold alcohol swab and pinprick at lateral, anterior and medial areas of thigh and postero-lateral area of gluteus using a 0 to 2 point scale. 0= no block, patients can feel cold; 1= analgesic block, patient can feel touch but not cold; 2= anesthetic block, patient cannot feel cold or touch.

Secondary

MeasureTime frameDescription
postoperative static pain at timepoint 2at 6 hours after surgeryVisual Analog Scale (VAS) score (0-10, 0 means no pain, 10 means the worst pain) of pain at rest will be recorded at several points of time within 24 hours after surgery: 1) 30mins after the patient recover from general anesthesia in postanesthesia care unit (PACU); 2) 6 hours after surgery;3) 12 hours after surgery; 4) 24 hours after surgery
postoperative static pain at timepoint 3at 12 hours after surgeryVisual Analog Scale (VAS) score (0-10, 0 means no pain, 10 means the worst pain) of pain at rest will be recorded at several points of time within 24 hours after surgery: 1) 30mins after the patient recover from general anesthesia in postanesthesia care unit (PACU); 2) 6 hours after surgery;3) 12 hours after surgery; 4) 24 hours after surgery
postoperative static pain at timepoint 4at 24 hours after surgeryVisual Analog Scale (VAS) score (0-10, 0 means no pain, 10 means the worst pain) of pain at rest will be recorded at several points of time within 24 hours after surgery: 1) 30mins after the patient recover from general anesthesia in postanesthesia care unit (PACU); 2) 6 hours after surgery;3) 12 hours after surgery; 4) 24 hours after surgery
postoperative static pain at timepoint 1at 30mins after the patient recover from general anesthesiaVisual Analog Scale (VAS) score (0-10, 0 means no pain, 10 means the worst pain) of pain at rest will be recorded at several points of time within 24 hours after surgery: 1) 30mins after the patient recover from general anesthesia in postanesthesia care unit (PACU); 2) 6 hours after surgery;3) 12 hours after surgery; 4) 24 hours after surgery
intraoperative sufentanil dosageduring the operationThe total intraoperative sufentanil dosage will be recorded
Incidence of block related adverse eventswithin 24hours after nerve block procedureIntraoperative and postoperative adverse events such as vascular puncture, local anesthetic systemic toxicity, epidural spread, etc.
Cumulative doses of intraoperative vasoactive medicationsduring the operationCumulative doses of intraoperative vasoactive medications (urapidil, atropine, ephedrine and deoxyepinephrine, etc.)
Performance time of blockDuring nerve block procedurePerformance time is defined as the time from insertion of the block needle (skin puncture) until finishing local anaesthetic (LA) injection

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026